AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
8,419.00
-14.00 (-0.17%)
Aug 25, 2025, 9:30 AM IST
AstraZeneca Pharma India Employees
AstraZeneca Pharma India had 802 employees as of March 31, 2025. The number of employees decreased by 138 or -14.68% compared to the previous year.
Employees
802
Change (1Y)
-138
Growth (1Y)
-14.68%
Revenue / Employee
23.13M INR
Profits / Employee
2.29M INR
Market Cap
210.79B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 802 | -138 | -14.68% |
Mar 31, 2024 | 940 | -7 | -0.74% |
Mar 31, 2023 | 947 | -236 | -19.95% |
Mar 31, 2022 | 1,183 | -100 | -7.79% |
Mar 31, 2021 | 1,283 | -42 | -3.17% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 42,497 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Alkem Laboratories | 18,785 |
AstraZeneca Pharma India News
- 10 days ago - AstraZeneca Pharma shares rise over 2% after company swings back to profit in Q1 - Business Upturn
- 10 days ago - AstraZeneca Pharma Q1 Results: Revenue up 36% YoY to Rs 526 crore, Net Profit at Rs 55 crore - Business Upturn
- 5 weeks ago - AstraZeneca Pharma gets CDSCO approval to import and sell Imfinzi for additional indication - Business Upturn
- 3 months ago - AstraZeneca Pharma India shares rally over 7% after strong Q4 results - Business Upturn
- 3 months ago - AstraZeneca Pharma receives CDSCO nod for expanded use of Fasenra in India - Business Upturn
- 6 months ago - AstraZeneca Pharma gets approval for additional indication of Durvalumab (Imfinzi) in India - Business Upturn
- 6 months ago - AstraZeneca receives approval to import Lokelma for hyperkalaemia treatment in India - Business Upturn
- 7 months ago - AstraZeneca receives approval to import and distribute Eculizumab - Business Upturn